Impella in Cardiogenic Shock: The Importance of Early Unloading

Dr. Giuseppe Tarantini (Professor and Director of Interventional Cardiology, University of Padua, Italy) speaks on the importan...

Dr. Alexander Truesdell: “Team of Teams” for Treating Cardiogenic Shock

Dr. Alex Truesdell of Virginia Heart discusses how a “team of teams” approach to treating cardiogenic shock can standardize...

Dr. Bill O’Neill: New Data from NCSI & Improving Outcomes in Cardiogenic Shock

“This is a coalition of the willing…I think all of you have to decide tomorrow when you go home, in your hospit...

Best Practices for Access and Closure with the Impella® Device

Dr. Shon Chakrabarti joins Dr. Alex Truesdell who talks to us about best practices for vascular access and closure and details...

Quick Tips on Access and Closure

Dr. Alex Truesdell provides his top 3 tips for safe access and closure with the Impella device which include utilizing all of y...

Considerations for Impella vs. ECMO

Dr. Michael Tong, Director of Heart Transplantation; Dr. Edward Soltesz, Surgical Director; and Dr. Shinya Unai, Cardiovascular...

Impella RP® Heart Pump Patient Selection Criteria Checklist

Use this FDA-approved checklist to guide treatment decisions and determine if the Impella RP is right for your patients....

Dr. Michael Amponsah Cardiogenic Shock Case with Impella CP

Dr. Michael Amponsah of Central New York Cardiology/Mohawk Valley Health System shares a case of Impella CP for a non-ischemic...

The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial

Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses...

Best Practice Protocols for Cardiogenic Shock Showing Improved Outcomes Within the WellStar System

Dr. Salvatore Mannino, Director of the Short-Term Mechanical Circulatory Support Program at WellStar Health System joins Dr. Se...

Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018

Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...

National Cardiogenic Shock Initiative: 1 Year Later

Video Chapters:The Impact of The Cardiogenic Shock Initiative (NCSI):...

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) da...

Cardiogenic Shock Due to Severe Multi-Vessel Disease

Dr. Alexander Truesdell, Interventional Cardiologist from Inova Heart & Vascular Institute, presents a case of cardiogenic...

Hybrid Closure Technique with Impella

Rajiv Tayal, MD, Director of Structural Heart Disease at JFK Medical Center, presents information from a clinical paper he co-a...

Step-by-Step Guide to Left Heart Unloading with Impella 5.0®

The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...

Step-by-Step Guide to Left Heart Unloading with Impella LD®

For patients in post cardiotomy cardiogenic shock (PCCS), the Impella LD can assist in the efforts to successfully unload the l...

Step-by-Step Guide to Right Heart Unloading with Impella® RP

The Impella RP is the only FDA approved support device for the treatment of right heart failure....

Left and Right-Side Impella Support in Cardiogenic Shock

Dr. Michael McDaniel of Emory School of Medicine and Dr. Rajesh Sachdeva of Morehouse School of Medicine present a case review...

Optimal Techniques for Gaining Femoral Access

Obtaining Femoral Access: Optimal Techniques Dr. Michael Lim of St. Louis University presents an overvi...

Identification of Complications and Early Management

Dr. Adhir Shroff of the University of Illinois at Chicago recently presented at the SCAI Fellows 2017 conference during a works...

Heart Team Approach to Treating Cardiogenic Shock

Dr. Alexander Truesdell of INOVA Heart and Vascular Institute compares his experience in combat medicine and combat medical car...

Abiomed Cardiogenic Shock Protocol

The Impella 2.5®, Impella CP® and Impella 5.0®/ Impella LD® Heart Pumps and Impella RP® Heart Pump, in conjunction with th...

Impella-Assisted Left Main Bifurcation Stenting

Columbia University Medical Center's Dr. Philip Green presents Impella-Assisted Left Main Bifurcation Stenting during ST elevat...

How to Better Evaluate, Identify and Manage Shock Patients

Recently, Abiomed’s platform of Impella® heart pumps received FDA approval for the treatment of patients experiencing cardio...

The FDA’s Shock Indication for the Impella

The FDA recently granted Abiomed approval to expand Impella™ 2.5 PMA to treat patients suffering cardiogenic shock follo...

Significance of FDA Approval of Impella for Cardiogenic Shock

Listen to Dr. William W. O’Neill, Medical Director for the Center for Structural Heart Disease at Henry Ford Hospital, discus...

Dr. Mark Grise Shares Advice on Access and Patient Management at Scripps 2015

The talk entitled “Tips and Tricks: Access and Patient Management” was given by Dr. Mark Grise, Medical Director of the Car...